Herschorn, Sender, Jameel Nazir, Barbara Ramos, and Zalmai Hakimi. “Cost-Effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada”. Canadian Urological Association Journal 11, no. 3-4 (April 11, 2017): 123–30. Accessed May 2, 2024. https://cuaj.ca/index.php/journal/article/view/4114.